Pre-Natal Exposure Screening Tools: The Maternal History Guide and Meconium FAEE Testing
- Dr. Moumita Sarkar, Coordinator Motherisk Alcohol and Substance Use Helpline, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children.
- Dr. Gideon Koren, Director Motherisk Program, The Hospital For Sick Children; Professor of Paediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics, University of Toronto.
The first part of the webinar will focus on the Maternal Drinking Guide (MDG). The purpose of the MDG is to identify women at risk of alcohol use in pregnancy. Maternal drinking history is necessary for improving identification of at-risk women and reducing risks for both mother and child. Due to concerns surrounding stigma, it is essential to utilize effective screening techniques to engage women of childbearing age and obtain accurate maternal alcohol use report. Knowledge of prenatal alcohol use is essential for 1) subsequent FASD diagnosis in the future and 2) harm reduction strategies. To investigate maternal drinking history, a systematic review of all evidence-based methods validated for detecting alcohol use in pregnancy was conducted. Evidence of maternal problem drinking or illicit drug use (as it is highly predictive of problem drinking) can be considered a “positive screen” to prompt FASD diagnostic testing of the child, if necessary. Although the maternal drinking guide provides several options, the most appropriate choice of screening tool(s) used will depend on provider expertise, practice and patient's characteristics.
Moumita Sarkar has over 10 years of professional experience in diverse areas such as health, education and prevention strategies. This encompasses research, coordination, presentations and publications. Since 2000, she has held the position of Co-ordinator for the Alcohol and Substance Use Helpline with The Motherisk Program, Hospital for Sick Children. Moumita Sarkar holds a PhD from the Institute of Medical Sciences at the University of Toronto with a collaborative degree in Addiction Medicine. Additionally, she has a Master of Science from the Faculty of Pharmacy, University of Toronto. Her doctoral thesis focused on use of evidence-based screening strategies to identify women exposed to alcohol and other recreational drugs. This led to the development of the maternal history guide that will be incorporated into a Canadian screening tool kit for FASD.
Dr. Koren is the founder and director of the Motherisk Program and a professor of Pediatrics, pharmacology, pharmacy and medicine. He is a staff pediatrician at The Hospital for Sick Children in Toronto and the author/co-author of hundreds of scientific articles, book chapters and abstracts. He is a member of numerous professional societies. In 1999 he received the Irving Sunshine Award (awarded by the International Association of Therapeutic Drug Monitoring & Clinical Toxicology), and in 1997 he received the prestigious Rawls-Palmer Award. Both awards were for outstanding contributions to clinical toxicology. In March 2000 Dr. Koren received the Medical Research Council of Canada’s Senior Scientist award for his work in Population Health Sciences, and in September 2003 he was awarded the Pippenger Award for outstanding achievement by the International Association for Therapeutic Drug Monitoring and Clinical Toxicology. Dr. Koren is founder of the FACE (Fetal Alcohol Canadian Expertise) Network and the peer reviewed Journal of FAS International. In 2004 Dr. Koren was appointed as the Ivey Chair in Molecular Toxicology at the University of Western Ontario. He is creating a Canadian Network of Human Toxicology.
This webinar was made possible through a contribution agreement between the Public Health Agency of Canada (PHAC) and the Canadian Association of Paediatric Health Centres.